Samuel Goldman

This inventor holds 22 USPTO granted patents and 1 published patent application, plus 1 CIPO patent, primarily in Immunology Treatments. Top assignees: Genetics Institute, Inc., Wyeth, University of Pittsburgh. Active years: 2000-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Samuel Goldman. Retrieved from https://idiyas.com/inventor/samuel-goldman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 1)

% Patents Active = 40.9

CIPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 5.5

ph-index = 9

Forward Citations = 406(Granted Patents)

Company Filing History:

15 out of 392

Genetics Institute, Inc.

University of Pittsburgh

patents

4. 1 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2012

Loading Chart...

Areas of Expertise:

IL-12 Antagonists

Autoimmune Diseases

Humanized Immunoglobulins

Interleukin-13

IL-17F

B7-2

Therapeutic Antibodies

Nucleic Acids

Polynucleotides

CTLA-8

Immune Modulation

Pharmaceutical Compositions

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8231874 - Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases (2012-07-31),

2. 8221752 - Antibodies against human interleukin-13 and uses therefor (2012-07-17),

3. 8012475 - Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases (2011-09-06),

4. 7943342 - Nucleic acids encoding IL-13 binding agents (2011-05-17),

5. 7704503 - Use of IL-17F in diagnosis and therapy of airway inflammation (2010-04-27),

6. 7666421 - Methods of treatment of autoimmune diseases using humanized immunoglobulin reactive with B7-2 (2010-02-23),

7. 7615213 - Antibodies against human interleukin-13 and pharmaceutical compositions thereof (2009-11-10),

8. 7534430 - Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases (2009-05-19),

9. 7531175 - Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules (2009-05-12),

10. 7501121 - IL-13 binding agents (2009-03-10),

11. 7419664 - Method of treatment using antibody to CLCA-1 (2008-09-02),

12. 7138115 - Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases (2006-11-21),

13. 6984383 - Method of transplanting cells by contacting donor cells with B7-1-and B7-2-specific immunoglobulins (2006-01-10),

14. 6972125 - Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith (2005-12-06),

15. 6913747 - Humanized immunoglobulin reactive with B7 therewith (2005-07-05),

Title: The Innovative Journey of Samuel Goldman

Introduction: Samuel Goldman, a distinguished inventor hailing from Acton, MA, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Samuel Goldman's latest patents include a cutting-edge smart home device that revolutionizes the way we interact with our living spaces, and a sustainable energy solution aimed at reducing carbon footprints.

Career Highlights: With a career spanning over two decades, Samuel Goldman has established himself as a visionary inventor with a keen eye for identifying gaps in the market and creating innovative solutions. His work has garnered recognition in various tech publications and has earned him several prestigious awards.

Collaborations: Throughout his career, Samuel Goldman has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has led to the successful development of groundbreaking technologies.

Conclusion: Samuel Goldman's relentless pursuit of innovation and his passion for creating technologies that improve lives have solidified his position as a trailblazer in the world of inventions. His work continues to inspire the next generation of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.